New Data From REZOLVE-AD Study Of Rezpegaldesleukin Presented In Late-Breaking Oral Abstract Presentation At ACAAI 2025 Annual Scientific Meeting. Statistically significant and clinically meaningful i ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback